Changes in chronic disease medication adherence following oral anticancer agent initiation in patients with multiple myeloma.

被引：0
|
作者：
Gatwood, Justin
Dashputre, Ankur
Wallace, Alex
Gatwood, Katie S.
Farris, Karen B.
Mackler, Emily R.
Rizvi-Toner, Amna
Rajpurohit, Abhijeet
Farley, Joel
机构：
[1] Univ Tennessee, Coll Pharm, Nashville, TN USA
[2] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[3] Univ Tennessee, Hlth Sci Ctr, Nashville, TN USA
[4] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[5] Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA
[6] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[7] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA
[8] Univ Minnesota, Coll Pharm, Dept Pharmaceut Care & Hlth Syst, Minneapolis, MN 55455 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18760
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18760
引用
收藏
页数：3
相关论文
共 50 条
  • [41] 99mTc tetrofosmin scintigraphy in the detection of disease activity in patients with multiple myeloma.
    Boz, A
    Karadogan, I
    Ugur, A
    Undar, L
    Gungor, F
    Yildiz, A
    Karayalcin, B
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 31P - 31P
  • [42] Evaluation of Medication Adherence in Chronic Kidney Disease Patients with and without Hemodialysis
    Kaul, Shaurya
    Ahsan, Amra
    Singh, Narinder Pal
    Khullar, Dinesh
    Gupta, Anish Kumar
    INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2023, 14 (03) : 162 - 167
  • [43] Patient-reported outcomes following autologous stem cell transplantation for patients with multiple myeloma.
    Biran, Noa
    Jensen, Roxanne
    Potosky, Arnold L.
    Siegel, David Samuel DiCapua
    Vesole, David H.
    Mandelblatt, Jeanne S.
    Richter, Joshua Ryan
    McClendon, Trina
    Kuo, Charlene
    Coleman, Claire
    Zotou, Vasiliki
    Li, Shaw
    Alintah, Princess
    McGuire, Colleen
    Rini, Christine
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Oral Anticancer Medication Adherence, Toxicity Reporting, and Counseling: A Study Comparing Health Care Providers and Patients
    Gandhi, Sonal
    Day, Larissa
    Paramsothy, Thivaher
    Giotis, Angie
    Ford, Maggie
    Boudreau, Angela
    Pasetka, Mark
    JOURNAL OF ONCOLOGY PRACTICE, 2015, 11 (06) : 498 - +
  • [45] Patients' Perception of App-based Educational and Behavioural Interventions for Enhancing Oral Anticancer Medication Adherence
    Ali, Eskinder Eshetu
    Leow, Jo Lene
    Chew, Lita
    Yap, Kevin Yi-Lwern
    JOURNAL OF CANCER EDUCATION, 2018, 33 (06) : 1306 - 1313
  • [46] Patients’ Perception of App-based Educational and Behavioural Interventions for Enhancing Oral Anticancer Medication Adherence
    Eskinder Eshetu Ali
    Jo Lene Leow
    Lita Chew
    Kevin Yi-Lwern Yap
    Journal of Cancer Education, 2018, 33 : 1306 - 1313
  • [47] Oral idarubicin as a single agent therapy in patients with relapsed or resistant multiple myeloma
    Sumpter, K
    Powles, RL
    Raje, N
    Ramiah, V
    Kulkarni, S
    Treleaven, J
    Mainwaring, PN
    LEUKEMIA & LYMPHOMA, 1999, 35 (5-6) : 593 - 597
  • [48] Z-Dex (oral idarubicin and dexamethasone) is effective initial therapy in the treatment of patients with multiple myeloma.
    Cook, G
    Iqbal, A
    Russell, NH
    Samson, D
    Sharp, RA
    Tansey, P
    Franklin, IM
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 209 - 209
  • [49] Combined analysis of British and German trials with oral idarubicin and dexamethasone in patients with newly diagnosed multiple myeloma.
    Glasmacher, A
    Cook, G
    Schmidt-Wolf, IG
    Goldschmidt, H
    BLOOD, 2003, 102 (11) : 451A - 451A
  • [50] A phase II trial of multi-agent maintenance therapy following autologous stem cell transplantation for multiple myeloma.
    Chen, CI
    Prabhu, A
    Sutton, D
    Stewart, AK
    BLOOD, 2001, 98 (11) : 166A - 166A
12345